Triple-negative breast cancer (TNBC), a subtype that lacks the expression of the oestrogen receptor, progesterone receptor and amplification of the ERBB2/HER2 gene, is a particularly aggressive form that presents a unique clinical challenge. Here, ERBB2 is linked to triple-negative breast carcinoma.